Fundz

Abk Biomedical reported raising $18.1 Million in an initial SEC Form D filing, from an offering of $18.1 Million

PRIVATESep 23, 2022

Amount Raised

$18.1 Million

$18.1 Million sold, per SEC Form D (first sale Sep 9, 2022)

Round Type

Venture

HalifaxOtherBiotechnologyHealth Care

Quick answer

ABK Biomedical raised $18.1 Million in a funding round, dated September 9, 2022. ABK Biomedical is based in Halifax, Nova Scotia, Canada.

How much did ABK Biomedical raise?
ABK Biomedical raised $18.1 Million in a funding round on September 9, 2022.
What does ABK Biomedical do?
ABK Biomedical is a company focused on researching, developing, and commercializing medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors.
Where is ABK Biomedical based and how big is it?
ABK Biomedical is based in Halifax, Nova Scotia, Canada. Fundz records about 42 employees.
Who are the decision-makers at ABK Biomedical?
Fundz holds 1 contact at ABK Biomedical, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as ABK Biomedical that raised within 45 days of this round, from Fundz verified event records.

  • DeepUll raised $13M (Series B) on October 20, 2022.
  • Orionis Biosciences raised $55M (Funding Round) on October 19, 2022.
  • Hemispherian AS raised $9.8M (Funding Round) on October 19, 2022.
  • Insmed Incorporated raised an undisclosed amount (Funding Round) on October 19, 2022.
  • Prenuvo raised $70M (Series A) on October 18, 2022.
  • Viome raised $67M (Series C) on October 18, 2022.

Who to call at ABK Biomedical, and when

A new round usually means ABK Biomedical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ABK Biomedical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ABK Biomedical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ABK Biomedical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ABK Biomedical

Location

155 Chain Lake Drive, Unit 32

Halifax, Nova Scotia, Canada

About

ABK Biomedical is a company focused on researching, developing, and commercializing medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors. ABK Biomedical holds intellectual property in the areas of inorganic polymer microspheres and unique administration systems. The company possesses advanced intellectual capital and its own R&D and manufacturing facilities for developing and commercializing unique embolotherapy products. Eye90 microspheres® is considered an investigational product and is not approved for use in any regulatory jurisdiction outside of approved clinical trials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ABK Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMichael M., Executive Officer, Director hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ABK Biomedical's next move

See what Strategic adds

ABK Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.